Inventaire - your friends and communities are your best library

Emerging biomarkers in glioblastoma

author

Mairéad Mcnamara

published in: Cancers

date of publication: 2013-08-22

main subject: biomarker, glioblastoma

Cites articles 56

Date

Title

Authors

2013-04-10

Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme

Hassan M Fathallah-Shaykh
2013-03-08

Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy

Elke Hattingen
2013-04

Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
2013-03-04

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
2013-01-09

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
2013-01-01

ELTD1, a potential new biomarker for gliomas

Jonathan Wren, David Gillespie
2013-01-04

DNA methylation profiles of long- and short-term glioblastoma survivors

Wenbin Wei, Eamonn R Maher
2013-02-07

Clinical implications of microRNAs in human glioblastoma

Nobuhiro Hata
2013-04-04

18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.

Joseph L Benci
2012-12-18

Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma

Andrei Thomas-Tikhonenko
2012-12-17

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

Consolación Melguizo, José C. Prados, Pablo Álvarez, Roberto Madeddu, Gloria Perazzoli, Fernando Rodríguez-Serrano
2012-12-13

Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers

Max Wintermark, Scott N Hwang, Rajan Jain, Tom Mikkelsen
2012-11-22

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
2012-11-16

Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies

Blandine Boisselier, Victor Enciso-Mora, Ahmed Idbaih, Richard Houlston
2012-10-12

MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma
2012-09-18

MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry
2012-07-01

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

Bert Vogelstein, Eric Lipp, Luis Alberto Diaz Jr, Henry Seth Friedman, Darell D. Bigner, Allan Friedman, Kenneth W Kinzler, Roger E McLendon, Peter C. Burger, Chetan Bettegowda, Zachary J Reitman, Suely Kazue Nagahashi Marie, Sueli Mieko Oba Shinjo, Patrick J Killela, Christopher J Pirozzi, Yuchen Jiao, Nishant Agrawal, Alan K Meeker, Nickolas Papadopoulos, Matthias Holdhoff, Christopher M Heaphy
2012-07-01

MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells

Stanley Thian Sze Wong
2012-04-01

Molecular profiling assays in breast cancer: are we ready for prime time?

Yesim Gokmen-Polar
2012-02-01

The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells
2012-03-18

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

Rajan Jain, Jonathan Goldin, Tom Mikkelsen, Patrick Y Wen, Timothy F. Cloughesy, Albert Lai, Phioanh Nghiemphu, Benjamin M Ellingson, Whitney Pope, James J Vredenburgh, Lauren E Abrey, Michael D Prados, Nina A. Paleologos
2012-01-15

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

Andreas von Deimling, Pieter Wesseling, Pierre Bady, Monika E Hegi, National Cancer Institute of Canada Clinical Trials Group, Michael Weller
2012-02-09

Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma

Timothy F. Cloughesy
2012-01-19

Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival

Hee-Jin Kim, Timothy F. Cloughesy, Stanley F Nelson
2011-12-27

CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays

Angelo L Vescovi, Jianhui Zhu, Francesco DiMeco
2011-10-11

Chemoresistance of glioblastoma cancer stem cells--much more complex than expected
2011-10-03

Conditional probability of survival in patients with newly diagnosed glioblastoma
2011-01-11

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

Henry Seth Friedman, Annick Desjardins
2011-01-10

A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations

Nathan D Price
2011-01

miRBase: integrating microRNA annotation and deep-sequencing data

Sam Griffiths-Jones
2011-04-09

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

Dominique Figarella-Branger
2011-10-12

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

Article - wd:Q37226521

Welcome to Inventaire

the library of your friends and communities

learn more